Christopher B O'Brien - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Christopher B O'Brien

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Transplantation|November 19, 2004

Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapyGuy W Neff, Marzia Montalbano, Christopher B O'Brien, et al.

Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 2, 2022

Is the Omicron variant truly less virulent in solid organ transplant recipients?Shweta Anjan, Akshay Khatri, Julia Bini Viotti, et al.

Clinical Transplantation|May 25, 2021

When is it safe to perform abdominal transplantation in patients with prior SARS-CoV-2 infection: A case seriesYoichiro Natori, Shweta Anjan, Eric F Martin, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Transplantation|November 19, 2004

Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapyGuy W Neff, Marzia Montalbano, Christopher B O'Brien, et al.

Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 2, 2022

Is the Omicron variant truly less virulent in solid organ transplant recipients?Shweta Anjan, Akshay Khatri, Julia Bini Viotti, et al.

Clinical Transplantation|May 25, 2021

When is it safe to perform abdominal transplantation in patients with prior SARS-CoV-2 infection: A case seriesYoichiro Natori, Shweta Anjan, Eric F Martin, et al.

Pageof 3